chenodeoxycholic acid has been researched along with Hepatitis C in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drew, L | 1 |
| Chang, KO; George, D; Patton, JB | 1 |
| Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
| Blanc, MC; Bonnefis, MT; Podevin, P; Poupon, R; Vaubourdolle, M; Veyrunes, C | 1 |
| Harihara, Y; Hashizume, K; Hirata, M; Ito, M; Kawarasaki, H; Kita, Y; Kusaka, K; Makuuchi, M; Nishimuraj, M; Saito, S; Sano, K; Yoshino, H | 1 |
5 other study(ies) available for chenodeoxycholic acid and Hepatitis C
| Article | Year |
|---|---|
Drug development: Sprint finish.
Topics: Animals; Biotechnology; Cardiovascular Diseases; Chenodeoxycholic Acid; Clinical Trials as Topic; Drug Discovery; Drug Industry; Hepatitis C; Humans; Liver Cirrhosis; Mice; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease | 2017 |
Bile acids promote HCV replication through the EGFR/ERK pathway in replicon-harboring cells.
Topics: Antiviral Agents; Bile Acids and Salts; Cell Cycle; Cell Line; Chenodeoxycholic Acid; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Genes, Reporter; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interphase; Luciferases, Renilla; Promoter Regions, Genetic; Quinazolines; Transcriptional Activation; Tyrphostins; Viral Nonstructural Proteins; Virus Replication | 2011 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Bile acid inhibition of interferon activity in human lymphocytes: no evidence of oxidative stress.
Topics: 2',5'-Oligoadenylate Synthetase; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Drug Resistance; Glutathione; Hepatitis C; Humans; In Vitro Techniques; Interferon alpha-2; Interferon-alpha; Lymphocytes; Malondialdehyde; Oxidative Stress; Recombinant Proteins | 1997 |
Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bile Acids and Salts; Biliary Atresia; Bilirubin; Chenodeoxycholic Acid; Child, Preschool; Female; Hepatitis C; Humans; Killer Cells, Natural; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Platelet Count; Regression Analysis | 2002 |